The breakthrough potential of aptamer therapeutics Adopting non-animal methods in drug development DNA aptamers: from mainstream to next-generation technologies Speeding the time-to-clinic with Optimer® Oligo therapeutics vs ADCs. How do they stack up? Aptamer-enhanced gene therapy delivery Aptamers enhance targeted gene therapy using viral vectors Aptamers in prostate cancer in vivo research Aptamer-based strategies for effectively crossing the Blood-Brain Barrier Aptamer based delivery of CRISPR/Cas9 for cancer gene therapy without the need for electroporation Aptamers and their applications in RNAi technology Aptamer mediated targeted delivery of cancer therapeutics Aptamers help to combat HIV Aptamers enhance Immune Cytotoxicity against cancer cells
